Issue 5/2021
Content (7 Articles)
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
Dee Lin, Philippe Thompson-Leduc, Isabelle Ghelerter, Ha Nguyen, Marie-Hélène Lafeuille, Carmela Benson, Panagiotis Mavros, Patrick Lefebvre
Amyotrophic Lateral Sclerosis
Review Article
Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis
Colin J. Mahoney, Rebekah M. Ahmed, William Huynh, Sicong Tu, Jonathan D. Rohrer, Richard S. Bedlack, Orla Hardiman, Matthew C. Kiernan
Hyperprolactinemia
Review Article
Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review
Frank M. C. Besag, Michael J. Vasey, Iffah Salim
Antidepressant Drugs
Review Article
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate Jr.
Migraine
Review Article
The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update
Christina Sun-Edelstein, Alan M. Rapoport, Wanakorn Rattanawong, Anan Srikiatkhachorn
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera® (Dimethyl Fumarate)
Thomas W. Lategan, Laurene Wang, Tiffany N. Sprague, Franck S. Rousseau
Open Access
Original Research Article
Disruption of Pharmacotherapy During the Transition from Adolescence to Early Adulthood in Patients with Attention-Deficit/Hyperactivity Disorder: A Claims Database Analysis Across the USA
Sepehr Farahbakhshian, Rajeev Ayyagari, Daniel S. Barczak, Simerpal K. Gill, Wenxi Tang, Thomas Kulalert, Madeline Jenkins, William Spalding